The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this enduring material for a maximum of 46.50 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: October 1, 2019
Termination Date: January 31, 2022 (Please note that AMA PRA Category 1 Credits ™ will no longer be issued for the activity after this date)
Estimated Time to Complete the Activity: 46.50 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

ABIM Medical Knowledge MOC Points

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 46.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

On the course evaluation page please indicate “Yes” when asked if you would like to receive ABIM MOC points for your participation in this enduring activity. You will then be required to provide your ABIM ID # and your Date of Birth. Points earned will equal the amount of AMA PRA Category 1 Credits ™ claimed.

HMS will upload the participant data, including the points earned, directly to the ABIM so that it will appear on the ABIM diplomates transcript. These points will not appear on your certificate provided at the end of this enduring activity.

Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Learning Objectives

After viewing this program, participants will be better able to:

Summarize current/recommended nephrology guidelines in clinical practice
Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
Identify/integrate current therapeutic options for specific renal disorders
Review and interpret up-to-date literature relevant to clinical practice
Describe pathophysiological mechanisms as they apply to management of renal disease
Apply learning objectives to the ABIM Nephrology certification/recertification examinations
ACGME Competencies

This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:

Patient Care and Procedural Skills
Medical Knowledge
Practice-Based Learning and Improvement
Target Audience

The target audience for the Intensive Review of Nephrology Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

Topics/Speaker:

Glomerulonephritis

Renal Physiology for the Boards – Melanie P. Hoenig, MD
Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon G. Bonegio, MD
Renal Pathology in 2019: Part 1 – Helmut G. Rennke, MD
Renal Pathology in 2019: Part 2 – Helmut G. Rennke, MD
Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MB BCh
Challenging Pathology Cases – Helmut G. Rennke, MD
IgA Nephropathy – Gerald B. Appel, MD
Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
Rapidly Progressive Glomerulonephritis – John L. Niles, MD
Update on Lupus Nephritis – Gerald B. Appel, MD
Glomerulonephritis: Questions & Answers Session – Gerald B. Appel, MD
Metabolic Management of Kidney Stones – Gary C. Curhan, MD, ScD
Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA
Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA
Electrolytes and Acid Base

Workshop: Hyponatremia and Hypernatremia – David B. Mount, MD
Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 1 – Alan S.L. Yu, MB, BChir
Hypokalemia and Hyperkalemia – David B. Mount, MD
Acidosis – Alan S.L. Yu, MB, BChir
Alkalosis – Alan S.L. Yu, MB, BChir
Cases from Renal Grand Rounds at The Brigham – David B. Mount, MD
Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 2 – Alan S.L. Yu, MB, BChir
Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
Update on Polycystic Kidney Disease – Ronald D. Perrone, MD
Pediatric Nephrology – Michael J.G. Somers, MD
Pregnancy and Renal Disease – Ravi I. Thadhani, MD, MPH
Geriatric Nephrology – Ernest I. Mandel, MD
Nephrology Board Review Practice 1 – Finnian R. McCausland, MB BCh, MMSc, FRCPI
CKD and General Nephrology

Update on Renovascular Disease – Joseph M. Garasic, MD
Management of Hypertension after SPRINT – Richard J. Glassock, MD
Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc
Cardiovascular Disease and Renal Disease – Finnian R. McCausland, MB BCh, MMSc, FRCPI
Liver and the Kidney – Andrew S. Allegretti, MD, MSc
Acute Kidney Injury

Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
Acute Kidney Injury Syndromes – Alice Sheridan, MD
Cancer and Acute Kidney Injury – Albert Q. Lam, MD
Paraprotein Induced Kidney Injury – Albert Q. Lam, MD
Clinicopathological Conference – Richard J. Glassock, MD, Joel M. Henderson, MD, PhD, and Martina M. McGrath, MB BCh
FSGS: A Lesion, Not a Disease – Richard J. Glassock, MD
Nephrology Board Review Practice 2 – Mallika Mendu, MD, MBA
ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
Interstitial Nephritis: Overview for the Boards – Julie M. Paik, MD, ScD, MPH
How to Pass the Boards – David E. Leaf, MD, MMSc
Transplantation

Why Do We Reject a Transplant? – Jamil R. Azzi, MD
Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP
Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
Early Post-Transplant Management – Anil K. Chandraker, MD
Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD
Late Loss of the Kidney Transplant – Andrew M. Siedlecki, MD
Infections in Transplant Recipients – Sarah P. Hammond, MD
Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD
Pre-Transplant Evaluation of Recipients – Jamil R. Azzi, MD, and Sayeed Malek, MD, FACS
Donor Evaluation – Kassem Safa, MD
Thrombotic Microangiopathies – Jean M. Francis, MD
Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
Transplant Board Review – Leonardo V. Riella, MD, PhD
Must Know Board Zebras – Emily S. Robinson, MD, MPH
Dialysis

Dialysis Dosing – J. Kevin Tucker, MD
Mineral and Bone Disease – David Bushinsky, MD
Dialysis: A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
Pearls in Mineral and Bone Disease – David Bushinsky, MD
Chronic Kidney Disease Epidemiology: A 2019 Update – Gearoid M. McMahon, MB BCh
Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC
Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
Dialysis Vascular Access: Assessment and Complications – Dirk M. Hentschel, MD